November 18th 2024
More than half of US adults—approximately 137 million—are candidates for semaglutide based on diabetes, weight management, or cardiovascular prevention indications.
November 16th 2024
SSRI Use Increases Risk of Post-Stroke Mortality in Patients with Diabetes
An analysis of population-based medical databases has found that strokes are more likely to prove fatal in diabetic patients who use selective serotonin reuptake inhibitors (SSRIs) than in diabetic patients who do not.
Ranibizumab Reduces Retinopathy Severity in Patients with Diabetic Macular Edema
After 12 or 24 monthly injections, ranibizumab, one of three currently available vascular endothelial growth factor antibodies, caused regression of diabetic retinopathy (DR) in at least 75% of patients who had diabetic macular edema and whose DR severity put them at the highest risk of progression to proliferative DR.